Records Management

PRODUCTS

  • Allogeneic CAR-T Cells Vs Autologous

    Chimeric antigen receptor (CAR) T cell therapy has emerged as one of the major breakthroughs in cancer immunotherapy in the last decade. Clinical trials with autologous CAR-T cells have shown very promising results and led to the approval of numerous CAR-T cell therapies.

  • The success of your clinical trial hinges on the patients you recruit. When you can’t find and enroll the right patients at the right time, you may experience go-to-market delays and financial losses. With AutoCruitment, you can secure the patients you need, complete your trial on time, and improve your study outcomes.

  • Neither traditional nor hybrid clinical trials can operate on rigid EDC systems.

    They require flexible data collection systems that support protocol amendments without downtime and accept mobile data without hassle. As a cloud-native solution, TrialKit bends to accommodate mid-study changes. And as the first full-featured EDC platform available as a native mobile app, TrialKit flexes to meet the demands of traditional, hybrid/decentralized, and completely remote clinical trials.

    Give your team the freedom to build, deploy, and manage their studies, their way—weeks faster than with rigid EDCs and for a fraction of the cost of the major players.

  • Advisory and execution services to efficiently advance new drugs and devices to market.

  • PHCbi brand's 18.6 cu.ft (528L) ultra-low temperature freezer operates on 220V and features VIP Plus vacuum insulated panels to deliver reliable temperature uniformity throughout the chamber. ENERGY STAR® Certified.

WHITE PAPERS AND CASE STUDIES

NEWS